Stay updated on Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page.
Latest updates to the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.0%
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe website has updated to version v2.10.2, adding 'Results Submitted' while removing 'No Results Posted' from version v2.10.0.SummaryDifference0.1%
- Check35 days agoNo Change Detected
- Check50 days agoChange DetectedThe website has been updated to version v2.10.0, adding 3 more interventions/treatments, 4 more study numbers, and noting that the study now has 158 locations.SummaryDifference0.3%
- Check57 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.0%
- Check71 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the version of the web page content.SummaryDifference0.0%
- Check76 days agoChange DetectedThe value of Last Update Posted (Estimated) Revision has changed from v2.9.3 to v2.9.5, indicating an update in the study record details.SummaryDifference0.0%
Stay in the know with updates to Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page.